{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:08:09Z","timestamp":1754194089357},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T00:00:00Z","timestamp":1409702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s11547-014-0434-8","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T04:39:36Z","timestamp":1409632776000},"page":"239-250","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?"],"prefix":"10.1007","volume":"120","author":[{"given":"Xiaoying","family":"Xing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangzhu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles A.","family":"Kirchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpaolo","family":"Pirovano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Iezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,3]]},"reference":[{"key":"434_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.rli.0000197668.44926.f7","volume":"41","author":"J Pintaske","year":"2006","unstructured":"Pintaske J, Martirosian P, Graf H et al (2006) Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 41:213\u2013221","journal-title":"Invest Radiol"},{"key":"434_CR2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.rli.0000184756.66360.d3","volume":"40","author":"M Rohrer","year":"2005","unstructured":"Rohrer M, Bauer H, Mintorovitch J et al (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715\u2013724","journal-title":"Invest Radiol"},{"key":"434_CR3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.rli.0000192421.81037.d5","volume":"41","author":"FL Giesel","year":"2006","unstructured":"Giesel FL, von Tengg-Kobligk H, Wilkinson ID et al (2006) Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents. Invest Radiol 41:222\u2013228","journal-title":"Invest Radiol"},{"key":"434_CR4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3174\/ajnr.A1185","volume":"29","author":"HA Rowley","year":"2008","unstructured":"Rowley HA, Scialfa G, Gao PY et al (2008) Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide. AJNR Am J Neuroradiol 29:1684\u20131691","journal-title":"AJNR Am J Neuroradiol"},{"key":"434_CR5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jmri.21695","volume":"29","author":"Z Rumboldt","year":"2009","unstructured":"Rumboldt Z, Rowley HA, Steinberg F et al (2009) Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of the CNS at 3 Tesla. J Magn Reson Imaging 29:760\u2013767","journal-title":"J Magn Reson Imaging"},{"key":"434_CR6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3174\/ajnr.A3033","volume":"33","author":"Z Seidl","year":"2012","unstructured":"Seidl Z, Vymazal J, Mechl M et al (2012) Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study). AJNR Am J Neuroradiol 33:1050\u20131058","journal-title":"AJNR Am J Neuroradiol"},{"key":"434_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1148\/radiol.2371041369","volume":"237","author":"F Pediconi","year":"2005","unstructured":"Pediconi F, Catalano C, Occhiato R et al (2005) Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 237:45\u201356","journal-title":"Radiology"},{"key":"434_CR8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2214\/AJR.07.3533","volume":"191","author":"F Pediconi","year":"2008","unstructured":"Pediconi F, Catalano C, Padula S et al (2008) Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine. AJR Am J Roentgenol 191:1339\u20131346","journal-title":"AJR Am J Roentgenol"},{"key":"434_CR9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1148\/radiol.10100968","volume":"258","author":"L Martincich","year":"2011","unstructured":"Martincich L, Faivre-Pierret M, Zechmann CM et al (2011) Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for breast MR imaging (DETECT Trial). Radiology 258:396\u2013408","journal-title":"Radiology"},{"key":"434_CR10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jmri.10313","volume":"17","author":"MV Knopp","year":"2003","unstructured":"Knopp MV, Giesel FL, von Tengg-Kobligk H et al (2003) Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 17:694\u2013702","journal-title":"J Magn Reson Imaging"},{"key":"434_CR11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1148\/radiol.10090357","volume":"255","author":"SC Gerretsen","year":"2010","unstructured":"Gerretsen SC, le Maire TF, Miller S et al (2010) Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries. Radiology 255:988\u20131000","journal-title":"Radiology"},{"key":"434_CR12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/RLI.0b013e31817d1505","volume":"43","author":"E B\u00fcltmann","year":"2008","unstructured":"B\u00fcltmann E, Erb G, Kirchin MA, Klose U, Naegele T (2008) Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced MR angiography of the supraaortic vessels at 3 Tesla. Invest Radiol 43:695\u2013702","journal-title":"Invest Radiol"},{"key":"434_CR13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1148\/radiol.2342040023","volume":"234","author":"M Prokop","year":"2005","unstructured":"Prokop M, Schneider G, Vanzulli A et al (2005) Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 234:399\u2013408","journal-title":"Radiology"},{"key":"434_CR14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-152-7-201004060-00008","volume":"152","author":"PD Stein","year":"2010","unstructured":"Stein PD, Chenevert TL, Fowler SE et al (2010) Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152:434\u2013443","journal-title":"Ann Intern Med"},{"key":"434_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10554-011-9821-6","volume":"28","author":"PK Woodard","year":"2012","unstructured":"Woodard PK, Chenevert TL, Sostman HD et al (2012) Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine. Int J Cardiovasc Imaging 28:295\u2013301","journal-title":"Int J Cardiovasc Imaging"},{"key":"434_CR16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.acra.2006.04.002","volume":"13","author":"NC Balci","year":"2006","unstructured":"Balci NC, Inan N, Anik Y et al (2006) Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging. Acad Radiol 13:833\u2013839","journal-title":"Acad Radiol"},{"key":"434_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004424-200302000-00003","volume":"38","author":"G Schneider","year":"2003","unstructured":"Schneider G, Maas R, Schultze Kool L et al (2003) Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison. Invest Radiol 38:85\u201394","journal-title":"Invest Radiol"},{"key":"434_CR18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3174\/ajnr.A3298","volume":"34","author":"Y Li","year":"2013","unstructured":"Li Y, Li X, Li D et al (2013) Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic Value Study). AJNR Am J Neuroradiol 34:847\u2013854","journal-title":"AJNR Am J Neuroradiol"},{"key":"434_CR19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jmri.24040","volume":"38","author":"J Wang","year":"2013","unstructured":"Wang J, Yan F, Liu J et al (2013) Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the peripheral VALUE study). J Magn Reson Imaging 38:926\u2013937","journal-title":"J Magn Reson Imaging"},{"key":"434_CR20","first-page":"499","volume":"21","author":"R Fontaine","year":"1954","unstructured":"Fontaine R, Kim M, Kieny R (1954) Die chirurgische Behandlung der peripheren Durch-blutungsst\u00f6rungen. Helv chir Acta 21:499\u2013533","journal-title":"Helv chir Acta"},{"key":"434_CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1148\/radiol.2431062144","volume":"243","author":"EA Sadowski","year":"2007","unstructured":"Sadowski EA, Bennett LK, Chan MR et al (2007) Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243:148\u2013157","journal-title":"Radiology"},{"key":"434_CR22","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/ndt\/gfm261","volume":"22","author":"P Marckmann","year":"2007","unstructured":"Marckmann P, Skov L, Rossen K et al (2007) Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 22:3174\u20133178","journal-title":"Nephrol Dial Transplant"},{"key":"434_CR23","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1681\/ASN.2007060645","volume":"18","author":"S Swaminathan","year":"2007","unstructured":"Swaminathan S, Shah SV (2007) New insights into nephrogenic systemic fibrosis. J Am Soc Nephrol 18:2636\u20132643","journal-title":"J Am Soc Nephrol"},{"key":"434_CR24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2451070353","volume":"245","author":"TA Collidge","year":"2007","unstructured":"Collidge TA, Thomson PC, Mark PB et al (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 245:168\u2013175","journal-title":"Radiology"},{"key":"434_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/radiol.2461071267","volume":"246","author":"E Kanal","year":"2008","unstructured":"Kanal E, Broome DR, Martin DR, Thomsen HS (2008) Response to the FDA\u2019s May 23, 2007, nephrogenic systemic fibrosis update. Radiology 246:11\u201314","journal-title":"Radiology"},{"key":"434_CR26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jcmg.2011.08.013","volume":"4","author":"Z Zou","year":"2011","unstructured":"Zou Z, Zhang HL, Roditi GH et al (2011) Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging 4:1206\u20131216","journal-title":"JACC Cardiovasc Imaging"},{"key":"434_CR27","unstructured":"Spinazzi A (2013) MRI contrast agents and nephrogenic systemic fibrosis. In: MRI bioeffects, safety, and patient management. Shellock FG, Crues JV (ed) Biomedical Research Publishing Group Chapter 11"},{"key":"434_CR28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/jmri.22355","volume":"32","author":"M Achenbach","year":"2010","unstructured":"Achenbach M, Figiel JH, Burbelko M, Heverhagen JT (2010) Prospective comparison of image quality and diagnostic accuracy of 0.5 molar gadobenate dimeglumine and 1.0 molar gadobutrol in contrast-enhanced run-off magnetic resonance angiography of the lower extremities. J Magn Reson Imaging 32:1166\u20131171","journal-title":"J Magn Reson Imaging"},{"key":"434_CR29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00004424-199712000-00009","volume":"32","author":"FM Cavagna","year":"1997","unstructured":"Cavagna FM, Maggioni F, Castelli PM et al (1997) Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780\u2013796","journal-title":"Invest Radiol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-014-0434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-014-0434-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-014-0434-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:33:04Z","timestamp":1559392384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-014-0434-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1007\/s11547-014-0434-8","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,3]]}}}